EU-Japan Biotech & Pharma Partnering Conference 2022
Lys Therapeutics, a french biotech company developing first-in-class biotherapies against neurological diseases and Grand-Prix i-Lab 2021, is announcing to participating to the EU-Japan Biotech & Pharma Partnering Conference 2022.
Don’t hesitate to reach Philippe Dujardin (CFO) and Dr. Manuel BLANC (CEO) for partnering discussions!
💻 Online 🗓 from 26-30 September 2022
📍 Onsite Partnering in Osaka 🗓 on 11 October 2022
The event is co-organised by the Osaka Prefectural Government, the EU-Japan Centre for Industrial Cooperation and the Enterprise Europe Network. It will be supported by various Bioclusters from Japan and Europe including CCI Normandie, CCI de région Auvergne-Rhône-Alpes and Pôle Lyonbiopôle.